North Carolina reports first flu death of 2026-27 season

North Carolina has reported its first flu death ​of the 2026-2027 season, state health officials said on Thursday, urging residents to get ‌vaccinated against seasonal respiratory illnesses.

US FDA flags four deaths in Newron's schizophrenia drug studies

Italy's Newron Pharmaceuticals said on Thursday the US FDA had identified four deaths ​among patients treated with its experimental schizophrenia drug in feedback following the agency's earlier decision to place a clinical hold ‌on the treatment's trial in the US.

Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal

Drugmaker Viatris said on Thursday it would buy Pacira BioSciences for $1.65 billion in ​cash, adding two non-opioid pain treatments to its portfolio as it looks to build out higher-value branded medicines beyond its core generics business.

Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble

Argenx said on Thursday it had discontinued ​a late-stage study of its efgartigimod drug in adults with Sjögren's disease, an autoimmune ‌condition that damages the glands producing tears and saliva, ⁠putting its shares ​on track for their ⁠biggest one-day fall in almost three ‌years.